News & Filings
EMCURE \u2014 Recent Activity
3 items in the last 14 days
Emcure Pharmaceuticals Ltd (BOM:544210) Q3 2026 Earnings Call Highlights: Strong Revenue Growth ...
Emcure Pharmaceuticals Ltd (BOM:544210) reports impressive revenue and profit growth, despite challenges in gross margins and increased competition.
Click to open →
Emcure Pharmaceuticals Ltd (BOM:544210) Q2 2026 Earnings Call Highlights: Record Profits and ...
Emcure Pharmaceuticals Ltd (BOM:544210) reports a 13% revenue increase and strategic moves in the obesity market, despite challenges in debt and margin stability.
Click to open →
Novo Nordisk, Emcure to launch weight-loss drug under new brand in India
(Reuters) -Novo Nordisk has partnered with India's Emcure Pharmaceuticals to exclusively distribute and market its weight-loss drug under a new brand in the country, the companies said on Monday.
Click to open →
Get alerts for important filings
Add EMCURE to your watchlist for board meeting & dividend alerts.
Open analysis →News from yfinance + BSE corporate announcements. Importance scoring is automated. YieldIQ is not registered with SEBI as an investment adviser.